SEC Form 4 · Rule 10b5-1 trading plans
Zai Lab Ltd (ZLAB)
- 23Trades filed under a plan
- 4Plan adoption dates stated
- 7Quarterly results prints on file
- 0Trades in the days before a print
In the 2025 filing year, Zai Lab Ltd filed 11 Form 4 statements whose footnotes name a Rule 10b5-1 trading plan, by 6 reporting owners, covering 23 transactions filed under those plans and 436,354 shares. 11 of those filings carry the SEC's own AFF10B5ONE adoption flag; the other 0 name a plan in a footnote and carry no flag. 7 results prints are on file in the same window, which is what makes the interval below measurable.
Trades filed under a plan in Zai Lab Ltd 23
- Du Ying — 2025-02-28 · S · 2,857 shares
- Du Ying — 2025-02-28 · S · 46,943 shares
- Du Ying — 2025-02-28 · S · 200 shares
- Edmondson Frazor Titus III — 2025-02-28 · S · 14,544 shares
- Lis William — 2025-02-28 · S · 15,000 shares
- Du Ying — 2025-03-03 · S · 23,110 shares
- Du Ying — 2025-03-03 · S · 24,280 shares
- Du Ying — 2025-03-03 · S · 2,610 shares
- Du Ying — 2025-03-04 · S · 6,665 shares
- Du Ying — 2025-03-04 · S · 37,752 shares
- Du Ying — 2025-03-04 · S · 5,583 shares
- Du Ying — 2025-03-05 · S · 21,093 shares
Plan adoption dates stated in Zai Lab Ltd 4
- 2024-05-29 — stated in 1 filing
- 2024-11-20 — stated in 5 filings
- 2024-11-22 — stated in 3 filings
- 2025-03-03 — stated in 2 filings
Quarterly results prints on file in Zai Lab Ltd 7
- 2025-02-27
- 2025-05-08
- 2025-08-07
- 2025-11-06
- 2026-02-26
- 2026-05-07
- 2026-08-06
Trades in the days before a print in Zai Lab Ltd 0
- 52 days before the 2025-05-08 print — 2025-03-17 · S · Amado Rafael · 3,000 shares
- 64 days before the 2025-05-08 print — 2025-03-05 · S · Du Ying · 21,093 shares
- 64 days before the 2025-05-08 print — 2025-03-05 · S · Du Ying · 25,296 shares
- 64 days before the 2025-05-08 print — 2025-03-05 · S · GAYNOR RICHARD · 2,500 shares
- 65 days before the 2025-05-08 print — 2025-03-04 · S · Du Ying · 6,665 shares
- 65 days before the 2025-05-08 print — 2025-03-04 · S · Du Ying · 37,752 shares
- 65 days before the 2025-05-08 print — 2025-03-04 · S · Du Ying · 5,583 shares
- 66 days before the 2025-05-08 print — 2025-03-03 · S · Du Ying · 23,110 shares
- 66 days before the 2025-05-08 print — 2025-03-03 · S · Du Ying · 24,280 shares
- 66 days before the 2025-05-08 print — 2025-03-03 · S · Du Ying · 2,610 shares
- 69 days before the 2025-05-08 print — 2025-02-28 · S · Du Ying · 2,857 shares
- 69 days before the 2025-05-08 print — 2025-02-28 · S · Du Ying · 46,943 shares
Interval to the next reported results date
For each transaction filed under a plan, the days between the transaction date and the company’s next results print. These are the dates the filings state, printed as an interval; the page draws no conclusion from them.
- 0Within 5 days of a print
- 0Within 10 days of a print
- 52Shortest interval, in days
- 0Trades with no later print on file
Adoption dates, as the filings state them
- 2024-05-29 stated in 1 filing
- 2024-11-20 stated in 5 filings
- 2024-11-22 stated in 3 filings
- 2025-03-03 stated in 2 filings
As the filings state it: “10b5-1 trading plan adopted by the Reporting Person on November 20, 2024”
Reported results dates on file
- 2025-02-27
- 2025-05-08
- 2025-08-07
- 2025-11-06
- 2026-02-26
- 2026-05-07
- 2026-08-06
A proxy statement is on file for this company in the same window, which is where a company states its own trading policy.
Other companies with plan records
- BRISTOL MYERS SQUIBB CO 1
- FMC CORP 2
- ELI LILLY & Co 4
- ABEONA THERAPEUTICS INC. 2
- HEXCEL CORP /DE/ 2
- TEVA PHARMACEUTICAL INDUSTRIES LTD 12
- Lifevantage Corp 1
- IONIS PHARMACEUTICALS INC 29
- VERTEX PHARMACEUTICALS INC / MA 22
- ARROWHEAD PHARMACEUTICALS, INC. 9
Order the document
Every company with plan records →
Form 4 statements and their footnotes from the SEC’s EDGAR full-text search, and this company’s results dates, industry classification and state of incorporation from the SEC submissions API. The page prints the dates the filings state and the interval between them; it draws no conclusion from them.